Judge Doubts Medicare Drug Pricing Amounts To 'Taking'

By George Woolston · March 7, 2024, 9:33 PM EST

A New Jersey federal judge on Thursday bristled at the position by pharmaceutical companies that Medicare's drug price negotiation program is an unconstitutional "taking" that undercuts their bottom line, suggesting that...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

BRISTOL MYERS SQUIBB COMPANY v. BECERRA et al

Case Number

3:23-cv-03335

Court

New Jersey

Nature of Suit

Civil Rights: Other

Date Filed

June 16, 2023

Case Title

JANSSEN PHARMACEUTICALS, INC. v. BECERRA et al

Case Number

3:23-cv-03818

Court

New Jersey

Nature of Suit

Civil Rights: Other

Date Filed

July 18, 2023

Case Title

NOVARTIS PHARMACEUTICALS CORPORATION v. BECERRA et al

Case Number

2:23-cv-14221

Court

New Jersey

Nature of Suit

Civil Rights: Other

Date Filed

September 01, 2023

Case Title

NOVO NORDISK INC. et al v. BECERRA et al

Case Number

3:23-cv-20814

Court

New Jersey

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

September 29, 2023

Recent Articles By George